Featured Question

Lack of effective therapies has been, and continues to be, an unmet need in the management of IBD. The first agent from a new class of biologic therapies—the adhesion molecule blockers/integrin antagonists—was recently FDA-approved for UC. How do these agents work? What is the latest evidence for their use in the care of these patients?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities


Latest Treatment Advances in MS: Need-to-Know Science and Implications for Practice

Course Director
Daniel Ontaneda, MD, MS
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio


Determining the Optimal Treatment Approach in Advanced Melanoma: Practical Considerations

Course Director
Antoni Ribas, MD, PhD
Jonsson Comprehensive Cancer Center
University of California Los Angeles
Los Angeles, California


Q&A: New and Emerging Options for the Treatment of Major Depressive Disorder

Course Director
Ian A. Cook, MD
David Geffen School of Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior
UCLA Brain Research Institute
Los Angeles, California


Cases in Point: Incorporating Novel Therapies for MS into Practice

Course Director
Aaron Boster, MD
The Ohio State University Multiple Sclerosis Center
The Ohio State University Medical Center
Columbus, Ohio


Q&A: Managing Pediatric and Adolescent Patients with T2DM

Course Director
Chhavi Agarwal, MD
Assistant Professor of Pediatrics
Albert Einstein College of Medicine
Bronx, New York


Q&A: Best Practices for Managing Low Testosterone in Men With Erectile Dysfunction

Course Director
Richard Sadovsky, MD
State University of New York
Downstate Medical Center
Brooklyn, New York


Emerging Treatments Show Promise for Improving Outcomes in Patients With Dermatologic Disorders

Course Director
Steven R. Feldman, MD, PhD
Psoriasis Treatment Center
Wake Forest University School of Medicine
Winston-Salem, North Carolina


Challenging Cases in Multiple Sclerosis

Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York